The 34th VETPHARM Symposium is a recognized scientific meeting in the field of veterinary pharmacology and toxicology that emphasizes translational and c omparative approaches\, as well as the development and application of 3R ( Replacement\, Reduction\, Refinement) methods. The symposium brings togeth er researchers\, clinicians\, veterinarians\, and toxicologists to discuss advances in drug safety\, toxicology\, new methodologies\, and regulatory aspects in animal health. \;
The 34th VETPHARM Symposium program ↗ includes multiple thematic sessions. Hi ghlights relevant to PARC include: \;
Among many high-level contr ibutions\, one PARC talk is scheduled as part of the 3R in vitro session. \;
Cody Adams-Niedergeses ↗ (University of Veterinary Medicine Hannover ↗\, Germany) will present a communication titled “PeriMyelinTox: Development of a Human Stem Cell-Based Demyelination Assay”. This presentation highlights PARC’s ongoing work in developing human-relevant in vitro assays and aligns with efforts to reduce animal use in neurotoxi city assessment.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260430T210515Z END:VEVENT BEGIN:VEVENT UID:69f3c40b918ed DTSTART;VALUE=DATE:20250926 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20250927 SUMMARY:Advances in Veterinary Pharmacology\, Toxicology\, and 3R Methods CLASS:PUBLIC DESCRIPTION:The 34th VETPHARM Symposium is a recognized scientific meeting in the field of veterinary pharmacology and toxicology that emphasizes tra nslational and comparative approaches\, as well as the development and app lication of 3R (Replacement\, Reduction\, Refinement) methods. The symposi um brings together researchers\, clinicians\, veterinarians\, and toxicolo gists to discuss advances in drug safety\, toxicology\, new methodologies\ , and regulatory aspects in animal health. \;The 34th VETPHARM Symposi um program ↗ includes multiple thematic sessions. Highlights relevant to PARC include: \;CNS pharmacology talks and a session on 3R in pain re search A session focused on mutagenesis and cancer in veterinary speciesA dedicated “3R in vitro” sessionRegulatory/pharmacovigilance presentati on slots \;Among many high-level contributions\, one PARC talk is sche duled as part of the 3R in vitro session. \;Cody Adams-Niedergeses ↗ (University of Veterinary Medicine Hannover ↗\, Germany) will present a communication titled “PeriMyelinTox: Development of a Human Stem Cell-B ased Demyelination Assay”. This presentation highlights PARC’s ongoing work in developing human-relevant in vitro assays and aligns with efforts to reduce animal use in neurotoxicity assessment. X-ALT-DESC;FMTTYPE=text/html:The 34th VETPHARM Symposium is a recognized scientific meeting in the field of veterinary pharmacology and toxicology that emphasizes translational and c omparative approaches\, as well as the development and application of 3R ( Replacement\, Reduction\, Refinement) methods. The symposium brings togeth er researchers\, clinicians\, veterinarians\, and toxicologists to discuss advances in drug safety\, toxicology\, new methodologies\, and regulatory aspects in animal health. \;
The 34th VETPHARM Symposium program ↗ includes multiple thematic sessions. Hi ghlights relevant to PARC include: \;
Among many high-level contr ibutions\, one PARC talk is scheduled as part of the 3R in vitro session. \;
Cody Adams-Niedergeses ↗ (University of Veterinary Medicine Hannover ↗\, Germany) will present a communication titled “PeriMyelinTox: Development of a Human Stem Cell-Based Demyelination Assay”. This presentation highlights PARC’s ongoing work in developing human-relevant in vitro assays and aligns with efforts to reduce animal use in neurotoxi city assessment.
X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260430T210515Z END:VEVENT END:VCALENDAR